Form 4: Coeptis Therapeutics Holdings CTO Reports Stock Transaction
Insider Transaction (Form 4)
Jeffery Keeslar Harris, Chief Technology Officer of Coeptis Therapeutics Holdings, Inc., reported multiple transactions in common stock on September 24, 2026.
Summary
- Option exercise/conversion: acquired 12,444 Common Stock on September 24, 2026; holds 12,444 after (Direct).
- Option exercise/conversion: disposed of 12,444 Restricted Stock Units on September 24, 2026; holds 37,334 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jeffery Keeslar Harris — Officer (Chief Technology Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-24 | Option exercise/conversion | Common Stock | 12,444 | — | — | 12,444 |
| 2026-09-24 | Option exercise/conversion | Restricted Stock Units | 12,444 | — | — | 37,334 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-24 | Option exercise/conversion (12,444 shares) |
| 2026-09-24 | Option exercise/conversion (12,444 shares) |
Keywords
insider transaction, Form 4, ZSQR, Z Squared Inc., neutral, Jeffery Keeslar Harris
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.